Tema Heart & Health ETF (HRTS)
NASDAQ: HRTS · Real-Time Price · USD
34.23
+0.77 (2.29%)
Apr 8, 2026, 2:18 PM EDT - Market open

HRTS Holdings Information

HRTS is an equity ETF with a total of 48 individual holdings. The top holdings are Eli Lilly and Company stock at 9.82%, AstraZeneca at 4.93%, Roche Holding AG at 4.84%, Johnson & Johnson at 4.78%, and Merck & Co. at 4.38%.

Total Holdings
48
Top 10 Percentage
46.80%
Asset Class
Equity
ETF Category
Health
Assets
50.78M
PE Ratio
21.55

Breakdown by Sector

Top 25 Holdings

No.SymbolName WeightShares
1LLYEli Lilly and Company9.82%5,413
2LON: AZNAstraZeneca PLC4.93%12,540
3RHHBYRoche Holding AG4.84%50,078
4JNJJohnson & Johnson4.78%10,139
5MRKMerck & Co., Inc.4.38%18,672
6TMOThermo Fisher Scientific Inc.3.99%4,185
7UNHUnitedHealth Group Incorporated3.85%7,159
8GILDGilead Sciences, Inc.3.59%13,261
9SWX: NOVNNovartis AG3.48%11,627
10ABTAbbott Laboratories3.15%15,809
11VRTXVertex Pharmaceuticals Incorporated3.14%3,689
12BBIOBridgeBio Pharma, Inc.2.88%20,327
13ABBVAbbVie Inc.2.82%6,953
14DHRDanaher Corporation2.80%7,557
15RVMDRevolution Medicines, Inc.2.28%11,839
16MDTMedtronic plc2.22%13,203
17CPH: NOVO.BNovo Nordisk A/S2.21%31,177
18BMYBristol-Myers Squibb Company2.19%18,939
19REGNRegeneron Pharmaceuticals, Inc.2.08%1,408
20MCKMcKesson Corporation2.05%1,196
21AMGNAmgen Inc.1.99%2,946
22TYO: 4519Chugai Pharmaceutical Co., Ltd.1.87%16,751
23BSXBoston Scientific Corporation1.86%15,285
24EWEdwards Lifesciences Corporation1.84%11,733
25TEVATeva Pharmaceutical Industries Limited1.77%30,273
Showing 25 of 48 holdings
Subscribe to see the full list
As of Apr 2, 2026